Novel approach: Herbal remedies and natural products in pharmaceutical science as nano drug delivery systems

International Journal of Pharmacy and Technology

Volumn 3, Issue 3, 2011, Pages 3092-3116

  Yadav, Deepak ^a   Suri, Suruchi ^a   Choudhary, Anis Ahmed ^a   Sikender, Mohd ^a   Hemant, ^a   Beg, Mohd Nadeem ^a   Garg, Veena ^b   Ahmad, Altaf ^a   Asif, Mohd ^a  

^a HAMDARD UNIVERSITY   (India)

^b BANASTHALI UNIVERSITY   (India)

Author keywords

Herbal remedies; Nanotechnology and drug delivery system; Natural products; Pharmaceutical science

Indexed keywords

DENDRIMER; HERBACEOUS AGENT; LIPOSOME; NANOPARTICLE; NATURAL PRODUCT; PLANT EXTRACT; POLYMERIC NANOPARTICLE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABILITY; BLEEDING DISORDER; COMBINATORIAL CHEMISTRY; COUGHING; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG INDICATION; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; MEDICINAL PLANT; MICELLE; MICROEMULSION; NANOTECHNOLOGY; PETAL; PLANT LEAF; PLANT ROOT; PRECIPITATION; SLOW RELEASE FORMULATION; TRADITIONAL MEDICINE; TUBERCULOSIS; TUMOR;

EID: 80053331216     PISSN: None     EISSN: 0975766X     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Newman DJ, Cragg GM (2007) Natural products as source of new drugs over the last 25 years. J. Nat. Prod. 70:461-477.
2. Butler MS (2008) Natural products to drugs: natural products-derived compounds in clinical trials. Nat. Prod. Rep. 25:475-516.
3. Ganesan A. (2008) The impact of natural products upon modern drug discovery. Curr. Opin. Chem. Boil. 12:306-317.
4. Charlish P (2008) Traditional remedies: latter day medicines. Scrip World Pharma. News. 3315:31-34.
5. Harvey AL (2008) Natural products in drug discovery. Drug Disc. Today. 13:19-20.
6. Borris J (1996) Natural products research: perspectives from a major pharmaceutical company, Merk Research Laboratories, J. Ethnopharmacol. 51:29.
7. Rishton GM (2008) Natural products as a robust source of new drugs and drug leads: past successes and present day issues. Am. J. Cardiol. 101:43D-49D.
8. McChesney JD (2007) Plant natural products: back to the future or into extiniction? Phytochem. 68:2015-2022.
9. Zhang MQ, Wilkinson B (2007) Drug discovery beyond the 'rule-of -five'. Curr. Opin. Biotechnol. 18:478-488.
10. Harvey AL (2001) Natural product pharmaceuticals: A diverse approach to drug discovery, Scrip. Reports. PJB Publications.
11. Wu S (2007) Multi-channel counter-current chromatography for high-throughput fractionation of natural products for drug discovery. J. Chromatogr. A1180:99-107.
12. Strohl RW (2000) The role of natural products in a modern drug discovery program. Drug Disco. Today. 5:2.
13. Wu XY, Lee PI (1993) Preparation and characterization of thermal and pH sensitive nanospheres. Pharm. Res. 10:1544-47.
14. Roggo S (2007) Natural Products in Drug Discovery. Chimia. 61:6.
15. Patwardhan B, Vaidya ADB, Mukund Chorghade M (2004) Ayurveda and natural products drug discovery. Cuurent Sci. 86:6.
16. Reich E, Schibli A, Debatt A (2008) Validation of High-Performance Thin-Layer Chromatographic Methods for the Identification of Botanicals in a cGMP Environment. NIH Public Access. 91(1):13-20.
17. Patwardhan B, Vaidya ADB, Chorghade M (2004) Ayurveda and natural products drug discovery. Curr. Sci. 86:789-799.
18. Khare CP (2004) Indian herbal remedies. Rational western therapy, Ayurvedic and other traditional usage, Botany. Springer; Berlin.
19. Vaidya ADB, Vaidya RA, Nagral SI (2001) Ayurveda and a different level of evidence: From Lord Macaulay to Lord Walton (1835-2001 A.D.). J. Assoc. Physicians of India. 49:534-537.
20. Chopra A, Doiphode V (2002) Ayurvedic medicine: Core concept, therapeutic principles and current relevance. Med. Clin. North Am. 86:75-89.
21. Rajasekaran S, Sivagnanam K, Subramanian S (2005) Mineral contents of aloe vera leaf gel and their role on streptozotocin-induced diabetic rats. Biol. Trace. Elem. Res. 108:185-195.
22. Dhuley JN (1999) Antitussive effect of Adhatoda vasica extract on mechanical or chemical stimulation-induced coughing in animals. J. Ethnopharmacol. 67:361-365.
23. Grange JM, Snell NJ (1996) Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro. J. Ethnopharmacol, 50:49-53.
24. Gogte VM (2002) Medicinal Plants, Part III in Ayurvedic Pharmacology and Therapeutic Uses of Medicinal Plants (Dravyagunavignyan), Mumbai Bhartiya Vidya Bhavan. 2nd Ed. 347-349.
25. Padhye S, Banerjee S, Ahmad A, Mohammad R, Fazlul H (2008) From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond. Cancer Ther. 6:495-510.
26. Rege N, Thatte U, Dahanukar S (1999) Adaptogenic property of six rasayana herbs used in Ayurvedic medicine. Phytother. Res. 13:275.
27. Atal CK, Zutshi U, Rao PG (1981) Scientific evidence on the role of Ayurvedic herbals on bioavailability of drugs. J. Ethnopharmacol. 4:229-232.
28. Rowinsky EK, Donehower RC (1995) Paclitaxel (Taxol). N. Engl. J. Med. 332:1004-1014.
29. Beppu H, Shimpo K, Chihara T, Kaneko T, Tamai I, Yamaji S, Ozaki S, Kuzuya H, Sonoda S (2006) Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice: investigation on hypoglycemic action and systemic absorption dynamics of aloe components. J. Ethnopharmacol. 103:468-477.
30. Rajka KS, Banerjee SK, Sood S, Dinda AK, Gupta YK, Gupta SK, Maulik SK (2004) Emblica officinalis causes myocardial adaptation and protects against oxidative stem in ischemic-reproduction injury in rats. Phytother. Res. 18:54-60.
31. Ziauddin M. (1996) Studies on the immunomodulatory effects of Ashwagandha. J. Ethnopharmacol. 50:69-78.
32. Mazumdar R, Bhatacharya S, Mazumdar A Pattnaik, Tiwary PM, Chaudhary S (2006) Antidiarrhoeal evaluation of Aegle marmelos (Correa) Linn. root extract. Phytother. Res. 20:82-84.
33. Pillai NR (1992) Antidiarrheal activity of Punica granatum in experimental animals. Int. J. Pharmacog. 30:201- 204.
34. Sharma VN (1969) Antiinflammatory activity of Ricinus communis Linn. (Eranda). J. Res. Indian Medicine. 4:47-50.
35. Banerjee A, Nigam SS (1978) Antimicrobial efficacy of the essential oil of Curcuma longa. Indian J. Med. Res. 68:864.
36. Kaura S, Aroraa S, Kaura K, Kumarb S (2002) The in vitro antimutagenic activity of Triphala - an Indian herbal drug. Food and Chemical Toxico. 40:527-534.
37. Hougee S, Faber J, Sanders A, De Jong RB, Van Den Berg WB, Garssen J, Hoijer MA, Smit HF (2005) Selective COX-2 inhibition by a Pterocarpus marsupium extract characterized by pterostilbene, and its activity in healthy human volunteers. Planta Med. 71:387-392.
38. Tripathi YB, Sharma M (2002) Comparison of the antioxidant action of the alcoholic extract of Rubia cordifolia with rubiadin. Indian J. Biochem. Biophys. 35:31.
39. Claeson UP, Malmfors T, Wikman G, Bruhn JG (2000) Adhatoda vasica: a critical review of ethnopharmacological and toxicological data. J. Ethnopharmacol. 72:1-20.
40. Barry VC, Conalty ML, Rylance ML, Rylance HJ, Smith FR (1955) Antitubercular effect of an extract of Adhatoda vasica. Nature., 176:119-120.
41. Kawai T (1990) Antiemetic principles of Magnolia ovata bark and Zingiber officinale rhizome. Plants Med. 56:17-20.
42. Karthikeyan K, Ravichandran P, Govindasamy S (1999) Chemopreventive effect of Ocimum sanctum on DMBA-induced hamster buccal pouch carcinogenesis. Oral Oncol. 35:112-119.
43. Prashar R, Kumar A, Banerjee S, Rao AR (1994) Chemopreventive action by an extract from Ocimum sanctum on mouse skin papillomagenesis and its enhancement of skin glutathione S-transferase activity and acid soluble sulfydryl level. Anticancer Drugs. 5:567-572.
44. Arici M, Sagdic O, Gecgel U (2005) Antibacterial effect of Turkish black cumin (Nigella sativa L.) oils. Grasas y Aceites 56:259-262.
45. Al-Ghamdi MS (2001) The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J. Ethnopharmacol. 76:45-48.
46. Indian Herbal Pharmacopoeia, (2002) Indian Drug Manufacturing Association. p. 317.
47. Van Vlerken LE, Amiji MM (2006) Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opinion Drug Deliv. 3:205-16.
48. Mecerreyes D, Lee V, Hawker C, Hedrick J, Wursch A, Volksen W, Magbitang T, Huang E, Miller R (2001) A Novel Approach to Functionalized Nanoparticles: Self-Crosslinking of Macromolecules in Ultradilute Solution, Advance Mater. 13:3.
49. Torchilin VP (2001) Structure and design of polymeric surfactant-based drug delivery systems, J. Control Release 73:137-172.
50. Singer JW, Baker B, De Vries P, Kumar A, Shaffer S, Vawter E, Bolton M, Garzone P (2003) Poly-(L)-glutamic acid-paclitaxel (CT-2103) [XYOTAX (TM)], a biodegradable polymeric drug conjugate- Characterization, preclinical pharmacology, and preliminary clinical data, Adv. Exp. Med. Biol. 519:81-99.
51. Mitra et al. (2001) Tumour Targeted Delivery of Encapsulated Dextran-Doxorubicin Conjugate Using Chitosan Nanoparticles as Carrier, J. Control. Rel. 74:317-323.
52. Avgoustakis K (2004) Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible application in drug delivery, Current Drug Deli. 1:321-333.
53. Lavasanifar A, Samuel J, Kwon GS (2002) Poly (ethylene oxide)-block-poly (L-amino acid) micelles for drug delivery, Adv. Drug Deliv. Rev. 54:169-190.
54. Wu XY, Yam F (2003) US6565872 - Polymeric system for drug delivery and solute separation.
55. Pouton CW (1985) Effects of the inclusion of a model drug on the performance self-emulsifying formulations, J. Pharm. Pharmacol. 5b:37, 1P.
56. Constantinides PP (1995) Lipid microemulsion for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects, Pharm. Res. 12(11):1561-1572.
57. Li Y, Dong L, Jia A, Chang X, Xue H (2006) Preparation and characterization of solid lipid nanoparticles loaded traditional chinese medicine, International Journal of Biological Macro. 38:296-299.
58. Bin Lu, Su-Bin Xiong, Hong Yang, Xiao-Dong Yin, Ruo-Bing Chao (2006). Solid lipid nanoparticles of mitoxantrone for local injectionagainst breast cancer and its lymph node metastases. European journal of pharma. Sci. 102:1202-1222.
59. Wu XY, Lee PI (1993) Preparation and characterization of thermal and pH sensitive nanospheres. Pharm. Res. 3(10):1544-47.
60. Zur Mühlen A, Schwarz C, Mehnert W. (1998) Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism. Eur J Pharm Biopharm. 45(2):149-55.
61. Grill AE, Johnston NW, Sadhukha T, Panyam J (2009) A Review of Select Recent Patents on Novel Nanocarriers. 3(2):137-142
62. Klajnert B, Bryzewska M (2001) Dendrimers: properties and applications. Acta Biochimica Polonica. 48(1):199-208.
63. Christopher JF, Nai-Ning Y, Shawn LR, Gabriel C, Gang-yu L (2011) High-Resolution Imaging of the Intramolecular Structure of Indomethacin-Carrying Dendrimers by Scanning Tunneling Microscopy ACS Nano. 5(3):1685-1692.
64. 2 G4 dendrimer and 5-fluorouracil in aqueous solution. Int J Pharm. 408(1-2):266-70.
65. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A (2007) Polymeric nanoparticle-encapsulated curcumin (nanocurcumin): a novel strategy for human cancer therapy, Journal of Nanobio. 5:1-18.
66. Zheng L, Song JF (2009) Curcumin multi-wall carbon nanotubes modified glassy carbon electrode and its electrocatalytic activity towards oxidation of hydrazine, Sensors and Actuators B: Chemical. 135:650-655.
67. Yen FL, Wu TH, Lin GT, Cham TM, Lin CC (2008) Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats, Food and Chemical Toxico. 46:1771-1777.
68. Zhang JF, Hou SX, Liu HL (2007) Comparison of preparing two polylactide nanoparticles loaded lipophilic anti-cancer herb drug by nanoprecipitation method]. Zhongguo Zhong Yao Za Zhi. 32(4):303-6.
69. Robinson JR (1996) Introduction: semi-splid formulations for oral drug delivery, Bulletin Technique, Gattefosse. 89:11-13.
70. Aungst BJ (1993) Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism, J. Pharm. Sci. 82:979- 987.
71. DeMario MD, Ratain MJ (1998) Oral chemotherapy: rationale and future directions, Journal of Clinical Oncolo.16:2557-2567.
72. Huizing MT, Sewberath Misser VH, Pieters RC, Ten Bokkel Huinink WW, Veenhof CHN, Vermorken JB, Pinedo HM, Beijnen JH (1995) Taxanes: a new class of antitumor agents, Cancer Invest. 13:381-4.
73. Pouton CW (1997) Formulation of self-emulsifying drug delivery systems, Adv. Drug Del. Rev. 25:47-58.
74. Mukerjee A, Vishwanatha JK (2009) Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 29(10):3867-75.
75. Lin AH, Li HY, Liu YM, (2007) Preparation and release characteristics of berberine chitosan nanoparticles in vitro[J].China Pharm. 18:755-757.
76. Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC. (2008) Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor-targeting in cancer therapy. Journal of Control. Rel. 127:208-218.
77. Chen Y, Lin X, Park H, Greever R (2009) Study of artemisinin nanocapsules as anticancer drug delivery systems Nanomedicine: Nanotechnology, Biology and Med. 5(3):316-322.
78. Li D, Zhong X, Zeng Z, Jiang J, Li L, Zhao M, Yang X, Chen J, Zhang B, Zhao QZ, Xie MY, Xiong H, Deng Z, Zhang X, Xu S, Gao Y (2009) Application of targeted drug delivery system in Chinese medicine Journal of Control. Rel. 138(2):103-112.
79. Yen FL, Wu TH, Tzeng CW, Lin LT, Lin CC (2010) Curcumin Nanoparticles Improve the Physicochemical Properties of Curcumin and Effectively Enhance Its Antioxidant and Antihepatoma Activities J. Agric. Food Chem. 58(12):7376-7382.
80. Hou J, Zhou SW, (2008) Formulation and preparation of glycyrrhizic acid solid lipid nanoparticles, ACTA Academiae medicinae militaris tertiae. 30:1043-5.
81. Roy S (2008) Why is a Novel Drug Delivery System Important for Herbal/Ayurvedic Medicines? AC Assosiated Content, Health and Wellness.